New cancer clinical trial: Safety of TT-00420 Monotherapy in Patients With Advanced Solid Tumors and Triple Negative Breast Cancer

Published on: August 31, 2018 at 12:00PM
Conditions:   Advanced Solid Tumors;   Triple Negative Breast Cancer
Intervention:   Drug: TT-00420
Sponsor:   TransThera Biosciences Co., Ltd
Not yet recruiting
https://ift.tt/2ou3opD